News Older →

• 

  A new SARS-Coronavirus protein inhibitor is a promising pan-coronavirus drug candidate

  Srijita Banerjee

  To combat the COVID-19 pandemic and potential future outbreaks, a collaborative study from Shiv Nadar Institute of Eminence (SNIoE), Noida, and other research institutes discovered a chemical compound called STL522228. This promising compound inhibits a crucial protein in the Severe Acute Respiratory Syndrome (SARS) coronavirus, shedding light on the pressing need for effective antiviral treatments.

  ---

• 

  Scientists inch closer to interpreting the stem cell code

  Divya Vishwanath

  Stem cells of an embryo are pluripotent – they can grow into almost any cell type in the body. Induced pluripotent stem cells (iPSC) are artificially reprogrammed body cells that can be made to function like embryonic stem cells, offering therapeutic advantages. However, understanding the genetic machinations of pluripotent stem cells is vital to successfully culture iPSC and is an active research area. In an exciting breakthrough, scientists have identified the group of genes responsible for maintaining distinct states of human pluripotency.

  ---

• 

  Malaria Control System: a digitised surveillance system to bolster the fight against malaria

  Joel P. Joseph

  Timely intervention is critical to curbing the spread of vector-borne diseases like malaria. A team of researchers from Mangaluru, Karnataka, has shown that information technology tools such as their Malaria Control System can be powerful allies in anti-malaria programs. Here is a report on how digitisation helped Mangaluru chalk its success story against malaria.